EM Oncology team participating in ESMO 24 – Dr. Reddy’s Laboratories
“Our Emerging Markets (EM) Oncology team is participating in the ESMO – European Society for Medical Oncology Conference from 13th-17th September in Spain.
The ESMO Congress is a platform for oncology where global clinicians, researchers, patient advocates, journalists and healthcare industry representatives come together, to present and discuss the latest scientific and clinical advances across the entire field of oncology.
ESMO 2024 will disseminate latest cutting-edge data, provide high-quality education and networking opportunities for oncologists and other stakeholders from all around the world. The conference is attended by more than 33,000 healthcare professionals (HCPs) every year.
We look forward to using this opportunity to interact with the scientific community, to showcase our capabilities, and to explore what we can do for patients and partners in oncology. Visit our booth 649 at ESMO to take this conversation forward.”
Sachin Vishwasrao, Therapy Lead of Oncology and Hospital Business (CoE Emerging Markets) at Dr. Reddy’s Laboratories, shared this post on LinkedIn:
“We at Dr.Reddy’s Laboratories are participating in ESMO 2024. Visit us to know more about our product portfolio, our presence across markets and partnership opportunities.”
Source: Dr. Reddy’s Laboratories/LinkedIn and Sachin Vishwasrao/LinkedIn